• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普萘洛尔对肝硬化患者服用呋塞米后尿前列腺素E2排泄及肾叶间动脉血流的影响。

Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.

作者信息

Ljubicić N, Bilić A, Plavsić V

机构信息

Department of Gastroenterology and Hepatology, University of Zagreb, General Hospital, "Sveti Duh", Republic of Croatia.

出版信息

Eur J Clin Pharmacol. 1992;43(5):555-8. doi: 10.1007/BF02285102.

DOI:10.1007/BF02285102
PMID:1483495
Abstract

The effect of propranolol on furosemide-stimulated urinary prostaglandin E2 (PGE2) excretion and renal blood flow was evaluated in 12 patients with alcoholic liver cirrhosis. Plasma and urine were collected before and 60 min after furosemide 20 mgI with or without propranolol pretreatment, and plasma renin activity (PRA), plasma aldosterone concentration (PAC), urinary excretion of PGE2 and sodium were determined. The renal interlobar arterial Pulsatility Index (PI), as an index of resistance to blood flow, was also determined before and 60 min after furosemide administration with and without propranolol pretreatment, by using a duplex Doppler ultrasound (Hitachi EUB 565). Urine volume and sodium excretion after furosemide administration were not influenced by the propranolol pretreatment. Furosemide administration significantly increased urinary PGE2 excretion, PRA and PAC, and these effects were significantly reduced by propranolol. Furosemide administration with or without propranolol significantly reduced renal interlobar arterial PI, the average reduction in PI being significantly lower after furosemide administration with propranolol pretreatment. The results demonstrate that propranolol pretreatment significantly influenced the furosemide-induced increase in urinary PGE2 excretion and renal interlobar arterial blood flow in cirrhotic patients.

摘要

在12例酒精性肝硬化患者中评估了普萘洛尔对速尿刺激的尿前列腺素E2(PGE2)排泄和肾血流量的影响。在给予20 mg速尿前及用药后60分钟采集血浆和尿液,速尿给药前或给药前给予普萘洛尔预处理,测定血浆肾素活性(PRA)、血浆醛固酮浓度(PAC)、PGE2和钠的尿排泄量。使用双功多普勒超声(日立EUB 565)在速尿给药前及给药后60分钟(有或无普萘洛尔预处理)测定肾叶间动脉搏动指数(PI),作为血流阻力指标。速尿给药后的尿量和钠排泄不受普萘洛尔预处理的影响。速尿给药显著增加尿PGE2排泄、PRA和PAC,而普萘洛尔可显著降低这些作用。速尿给药(有或无普萘洛尔)显著降低肾叶间动脉PI,普萘洛尔预处理后速尿给药时PI的平均降低幅度显著更低。结果表明,普萘洛尔预处理显著影响肝硬化患者速尿诱导的尿PGE2排泄增加和肾叶间动脉血流增加。

相似文献

1
Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.普萘洛尔对肝硬化患者服用呋塞米后尿前列腺素E2排泄及肾叶间动脉血流的影响。
Eur J Clin Pharmacol. 1992;43(5):555-8. doi: 10.1007/BF02285102.
2
The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.
Eur J Clin Pharmacol. 1987;31(5):605-7. doi: 10.1007/BF00606639.
3
Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.速尿给药后血管紧张素II在肾前列腺素E2生成中的作用。
Hypertension. 1988 May;11(5):491-4. doi: 10.1161/01.hyp.11.5.491.
4
Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Eur J Clin Invest. 1990 Dec;20(6):632-41. doi: 10.1111/j.1365-2362.1990.tb01912.x.
5
Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers.选择性抑制诱导型环氧化酶对健康志愿者肾素释放的影响。
J Investig Med. 1998 Aug;46(6):290-6.
6
Effect of propranolol treatment on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.普萘洛尔治疗对原发性高血压患者前列腺素E2和F2α尿排泄的影响。
Isr J Med Sci. 1982 Feb;18(2):231-4.
7
Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Prostaglandins Med. 1980 Jul;5(1):1-9. doi: 10.1016/0161-4630(80)90085-3.
8
Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.肾病综合征和肝硬化时肾脏对钠和水排泄的调节
Dan Med Bull. 1997 Apr;44(2):191-207.
9
Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats.血管紧张素II 1型受体拮抗剂对大鼠使用呋塞米后尿前列腺素E2排泄的影响。
Life Sci. 1994;55(9):707-11. doi: 10.1016/0024-3205(94)00678-4.
10
Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.速尿、血管紧张素转换酶抑制剂、肾多巴胺与前列腺素:正常人的急性相互作用
Br J Clin Pharmacol. 1989 Dec;28(6):683-94. doi: 10.1111/j.1365-2125.1989.tb03561.x.

引用本文的文献

1
Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysis.肾素-血管紧张素-醛固酮抑制剂与β受体阻滞剂联合治疗对比β受体阻滞剂单药治疗对肝硬化门静脉高压血流动力学的影响:一项荟萃分析
Exp Ther Med. 2017 May;13(5):1977-1985. doi: 10.3892/etm.2017.4210. Epub 2017 Mar 9.
2
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.重症监护病房感染治疗的药代动力学方面:聚焦于药物相互作用。
Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004.
3
Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.

本文引用的文献

1
Noninvasive characterization of renal artery blood flow.肾动脉血流的无创性特征分析
Kidney Int. 1981 Oct;20(4):523-9. doi: 10.1038/ki.1981.171.
2
Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.选择性和非选择性β受体阻滞剂降低肝硬化和门静脉高压患者门静脉压力的作用
Gut. 1984 Feb;25(2):121-4. doi: 10.1136/gut.25.2.121.
3
Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man.前列腺素对正常男性呋塞米所致全身及肾血管反应的作用。
普萘洛尔和5-单硝酸异山梨酯给药对肝硬化患者肾血流量的急性影响。
Gut. 1998 Feb;42(2):283-7. doi: 10.1136/gut.42.2.283.
Br J Clin Pharmacol. 1984 May;17(5):513-9. doi: 10.1111/j.1365-2125.1984.tb02383.x.
4
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report.普萘洛尔预防肝硬化患者复发性胃肠道出血的随机对照研究:最终报告
Hepatology. 1984 May-Jun;4(3):355-8. doi: 10.1002/hep.1840040301.
5
Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.普萘洛尔对肝硬化患者肾血流量及肾功能的影响。
Gastroenterology. 1984 Jan;86(1):129-33.
6
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.普萘洛尔对肾素分泌的抑制作用。一种诊断和治疗肾素依赖性高血压疾病的特定方法。
N Engl J Med. 1972 Dec 14;287(24):1209-14. doi: 10.1056/NEJM197212142872401.
7
Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma.人血浆中前列腺素E、A和F的放射免疫分析测定
J Clin Invest. 1973 Feb;52(2):398-405. doi: 10.1172/JCI107196.
8
Blood flow in deep abdominal and pelvic vessels: ultrasonic pulsed-Doppler analysis.腹部深部和盆腔血管中的血流:超声脉冲多普勒分析
Radiology. 1985 Feb;154(2):487-93. doi: 10.1148/radiology.154.2.3880913.
9
The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.
Eur J Clin Pharmacol. 1987;31(5):605-7. doi: 10.1007/BF00606639.
10
Noninvasive Doppler assessment of renal artery stenosis and hemodynamics.肾动脉狭窄和血流动力学的无创多普勒评估
J Clin Ultrasound. 1987 Nov-Dec;15(9):653-9. doi: 10.1002/jcu.1870150908.